@jhmmd
Tort reform is absolutely needed for cost containment and to improve quality of healthcare (and likely will reduce harm from unnecessary follow up invasive studies)
but I do not think it will make midlevels less prevalent. It may make them more prevalent if physicians (and by extension, 'practitioners') less likely to be sued. I am a HUGE proponent of tort reform but I think it will make midlevels more abundant, not less, and hospitals more likely to use them, not less.
What is an all in one outpatient center?
Two on your list is happening. We'll see what comes of it. The vast majority of that occurs on the insurance/physician/hospital interface side and not on the patient side so I'm not sure this will really alter the midlevel landscape either. We will see one way or another.
Three is probably a lost cause.
Five is happening in a lot of places. That is one huge benefit of these big healthcare conglomerations popping up and big systems gobbling up smaller systems and many of us becoming employed. And I do actually think it puts huge guard rails and constraints on midlevels in those sorts of systems because a lot of things start to get standardized and protocolized over time. I can really only speak from the cancer perspective, but all of our treatment plans for... literally everyone pretty much, happens in a tumor board. Midlevels can't and don't present there but are heavily utilized by every service line - to execute the plans of the physicians at tumor board. It works quite well. It also clearly defines scope, it ensures patients are being treated with standards of care, and if you're going off the road map and inventing medicine, its done under the oversight of an entire panel of physicians and not just one person who's got a feeling. I wish multi-D conferences were actually a thing for every aspect of medicine. Its kind of painful and time consuming to get everyone in the room (or on the teams meeting, these days) but it is really stupidly effective and there's no denying that. So, hard agree for #5.
Hard disagree for #6 - mostly because of #5. But again, I'm talking from my n=1 of cancer. By working in a giant system, we've been able to centralize the dangerous **** (rare cancers, big operations, plans for things that are not standard and/or zebra) and come up with a plan at the mothership that can be executed nearly anywhere in the state except the dangerous ****. We've gotten so good at it that our med-oncs and/or general surgeons are able to do some follow up stuff post-surgery for the physical piece (take out staples, wound check) hundreds of miles away while the primary surgeon can do a zoom call. That works in pre-op too; with how we utilize medicine for pre-operative optimization and 'clearance', how reliant we are on imaging and objective data to guide treatment, etc., the physical exam is really mostly to check your scars and get an idea of your body habitus and if there will be any weird other unanticipated things for the surgery.
In peak Covid time the H&P was done the morning of surgery and we met people for whipples the day of. That was weird, and it WAS less than ideal, but it also worked. We relied on our med-oncs who were the primary point person hundreds of miles away to give us detailed information and simply having a patient lift up their shirt to show us their belly on zoom. Again - weird. But it wasn't bad. We had no misses. We had no unplanned conversions from MIS to open surgery. We had no cancelled cases for patients being poor functional/ECOG status. I could absolutely see implementing this all the time to overcome huge travel distances for specialized care. I readily admit, and will not even begin to comment, on what telehealth has been like for a primary care/medical doc not in cancer. I've no idea.
I'm curious why you said #6 and would like you to elaborate more if you're up for it.
For a large system with differing levels of care across many hospitals and clinics though telehealth has been fantastic.